Valuation: Futura Medical plc

Market Cap 2.09M 2.82M 2.47M 2.28M 3.96M 272M 4.03M 27.2M 10.68M 133M 10.6M 10.36M 458M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.31M -1.76M -1.54M -1.43M -2.48M -170M -2.52M -17.01M -6.68M -83.03M -6.63M -6.48M -287M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
83.88%
Yield 2024 *
-
Yield 2025 -
1 day+11.11%
Current month-23.08%
1 month-33.33%
3 months-66.67%
6 months-69.63%
Current year-64.13%
1 week 0.3
Extreme 0.301
0.5
1 month 0.24
Extreme 0.244
0.7
Current year 0.24
Extreme 0.244
1.75
1 year 0.24
Extreme 0.244
14.85
3 years 0.24
Extreme 0.244
61.5
5 years 0.24
Extreme 0.244
67
10 years 0.24
Extreme 0.244
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12/8/25 Buy

Chief Financial Officer

500,000 0.1488%
12/8/25 Buy

Chief Executive Officer

5,000,000 1.4876%
12/8/25 Buy

Chief Technology Officer

500,000 0.1488%
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%0.00%-96.02%-99.24% 2.82M
-3.42%+10.05%+58.59%+87.70% 57.82B
-0.05%-5.85%+54.36%+71.44% 53.71B
-2.06%-8.92%+2.98%+420.34% 23.8B
-0.15%-1.03%-18.20%-14.17% 23.26B
-0.56%+10.26%+44.03%-3.86% 20.7B
-0.29%-2.05%+34.41%-29.62% 17.81B
-4.55%-8.65%+194.32%+349.58% 16.9B
-2.61%+8.99%+46.11%+691.67% 16.36B
+0.86%-2.24%+24.57%+190.88% 13.96B
Average -0.16%-0.05%+34.52%+166.47% 24.43B
Weighted average by Cap. -1.54%+0.18%+48.54%+154.96%

Financials

2024 2025
Net sales 13.93 18.77 16.41 15.18 26.36 1.81K 26.81 180.99 71.1 883.41 70.5 68.95 3.05K 1.7 2.29 2 1.85 3.21 220.4 3.27 22.05 8.66 107.63 8.59 8.4 371.58
Net income 1.29M 1.74M 1.52M 1.41M 2.45M 168M 2.49M 16.8M 6.6M 82.02M 6.55M 6.4M 283M -9.07M -12.23M -10.69M -9.88M -17.17M -1.18B -17.47M -118M -46.31M -575M -45.92M -44.91M -1.99B
Net Debt -6.6M -8.89M -7.77M -7.19M -12.48M -857M -12.7M -85.73M -33.68M -418M -33.39M -32.66M -1.44B -3.4M -4.59M -4.01M -3.71M -6.44M -442M -6.55M -44.21M -17.37M -216M -17.22M -16.84M -745M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-07-16 GBX 0.4000 +11.11% 7,168,816
26-07-15 GBX 0.3600 0.00% 3,587,949
26-07-14 GBX 0.3600 -2.70% 1,549,909
26-07-13 GBX 0.3700 0.00% 10,537,994
26-07-10 GBX 0.3700 -7.50% 12,351,521

Annual profits - Rate of surprise